Clinical Trials on Mycobacterium Infections, Non-tuberculous in France

Total 168 results

BioMérieux

Completed

Performance Evaluation of the VIDAS TB-IGRA Assay.

Active Tuberculosis | Latent Tuberculosis Infection | Non-Tuberculous Mycobacterial (NTM) Pneumonia

United States, France, United Kingdom, India, Brazil, Georgia, Italy, Mexico, South Africa
University Hospital, Strasbourg, France

Recruiting

State of Play of Non-tuberculous Mycobacteria in Alsace (Mycoba)

Non-Tuberculous Mycobacteria

France
University Hospital, Montpellier

Completed

Osteoarticular Infections on Material in Children

Osteoarticular Tuberculoses

France
Hospices Civils de Lyon

Recruiting

Immunological Biomarkers in Tuberculosis Management (OPTI-4TB)

Tuberculosis | Tuberculosis Infection

France
Centre Hospitalier Universitaire de Nice

Completed

Time-to-Detection in Culture of Mycobacterium Tuberculosis

Pulmonary Tuberculoses

France
University Hospital, Montpellier

Completed

COMPArison of Screening Strategies for Active TuBerculosis (COMPASS-TB) (COMPASS-TB)

Latent Tuberculosis | Active Tuberculosis

France
Assistance Publique - Hôpitaux de Paris

Completed

Medical and Economical Impact of IGRAs Diagnosis of Latent Tuberculosis in HIV-infected Patients (IGRAVIH)

HIV | Tuberculosis | Latent Tuberculosis Infection

France
Assistance Publique - Hôpitaux de Paris

Completed

Positron Emission Tomography in Extrapulmonary Tuberculosis (TUBOGTEP)

Extrapulmonary Tuberculosis | Lymph Node Tuberculosis | Bone Tuberculosis

France
University Hospital, Brest

Unknown

Epidemiology and Clinical Characteristics of Non-Tuberculous Mycobacteria Infections in Cystic Fibrosis Patients. (CIMENT)

Cystic Fibrosis

France
Assistance Publique - Hôpitaux de Paris

Completed

Quantiferon for Detection of Latent Tuberculosis in Healthcare Workers (QUANTIPS)

Tuberculosis

France
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID); Federal University... and other collaborators

Recruiting

Point-of-care Pharmacogenomic Testing to Optimize Isoniazid Dosing for Tuberculosis Prevention

Tuberculosis Infection | Isoniazid Adverse Reaction

Brazil
Assistance Publique - Hôpitaux de Paris

Completed

Impact of New Immunological Diagnosis Tests of Latent Tuberculosis Before Anti TNF Therapy (ETAT)

Tuberculosis

France
Assistance Publique - Hôpitaux de Paris

Recruiting

Evaluation of the Early Bactericidal Activity of Tedizolid and Linezolide Against Mycobacterium Tuberculosis (TEDITUB) (TEDITUB)

Tuberculosis | Multidrug Resistant Tuberculosis

France
Centre Hospitalier Universitaire, Amiens

Completed

Treatment of Mycobacterium Xenopi Pulmonary Infection (CAMOMY)

Atypical; Mycobacterium, Pulmonary, Tuberculous

France
Assistance Publique - Hôpitaux de Paris

Recruiting

New Genomic Techniques and Management of Multidrug-resistant Tuberculosis (GENO-MDR)

Multi-Drug Resistant Tuberculosis

France
University Hospital, Montpellier

Terminated

Serological Test for the Diagnosis of TB (MycoTB)

Active Tuberculosis

France
Assistance Publique - Hôpitaux de Paris

Completed

Paradoxical Reactions in Non Immuno-compromized Patients With Extrapulmonary Tuberculosis (PARATB)

Extrapulmonary Tuberculosis

France
Assistance Publique - Hôpitaux de Paris

Completed

Bone Resistant Tuberculosis (TboneR)

Bone and Osteoarticular Infection Due to MDR M. Tuberculosis Strains

France
Centers for Disease Control and Prevention
Tuberculosis Trials Consortium

Recruiting

Short-course Regimens for the Treatment of Pulmonary Tuberculosis (CRUSH-TB)

Tuberculosis, Pulmonary | Tuberculosis Infection

Canada, United States, Haiti, South Africa, Uganda, Vietnam
Centre Hospitalier Universitaire, Amiens

Recruiting

CLArithromycin Versus AZIthromycin in the Treatment of Mycobacterium Avium Complex (MAC) Lung Infections (CLAZI)

Mycobacterium Avium Complex | Lung Infection

France
University Hospital, Strasbourg, France

Recruiting

Epidemiological Study of Hospitalized Children for Pulmonary Tuberculosis at Strasbourg University Hospitals (TPE)

Pulmonary Tuberculosis

France
Assistance Publique - Hôpitaux de Paris

Unknown

Tuberculosis Cohort in the North of Paris

Pulmonary Tuberculosis | Extra Pulmonary Tuberculosis

France
Assistance Publique Hopitaux De Marseille

Completed

Improving the Diagnostic of Tuberculosis

Tuberculosis

France
Assistance Publique - Hôpitaux de Paris

Unknown

Local Anesthesia and Tuberculin Skin Test in Infants and Children

Tuberculosis

France
Centre Hospitalier Universitaire, Amiens

Recruiting

Relevance of Isoniazid Dosage in Adults Treated for Tuberculosis (ISOBK)

Tuberculosis

France
University Hospital, Strasbourg, France

Unknown

A Multidrug-resistant (MDR) and Extensively Drug- Resistant (XDR) Tuberculosis Study in Alsace

Tuberculosis

France
Groupe Hospitalier Paris Saint Joseph

Completed

Pharmacokinetic and Therapeutic Adaptation of Linezolid in the Treatment of Multi-Resistant Tuberculosis (LINEZOLIDE)

Tuberculosis

France
Biomedical Research Center EPLS
University of Cape Town; Biofabri, S.L; TuBerculosis Vaccine Initiative; Universidad... and other collaborators

Completed

Epidemiological Study In Tuberculosis-Endemic Urban Area in Senegal (MTBVAC-EPI)

Tuberculosis

France
Hopital Lariboisière

Completed

Comparison Between Two Strategies for the Diagnosis of TB

Pulmonary TB

France
ANRS, Emerging Infectious Diseases
Merck Sharp & Dohme LLC; Ministry of Health, Brazil

Completed

Raltegravir Versus Efavirenz in Naive HIV-1-infected Patients Receiving Rifampin for Active Tuberculosis (REFLATE TB2)

Tuberculosis | HIV-1 Infection

France, Vietnam, Brazil, Côte D'Ivoire, Mozambique
Assistance Publique - Hôpitaux de Paris

Recruiting

Tuberculosis Cohort Avicenne Hospital (COTB-AVC)

Tuberculosis, Pulmonary

France
Assistance Publique - Hôpitaux de Paris

Terminated

Performance of IGRAs for TB Infection Diagnosis in Elderly (IGRage)

Tuberculosis | Ageing

France
Assistance Publique - Hôpitaux de Paris

Completed

Rapid Detection of Rifampin and Isoniazid Resistance by PCR Before Tuberculosis (TB) Treatment Initiation (FAST-TB)

Tuberculosis

France
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Terminated

Rifampin-Based Tuberculosis Treatment Versus Rifabutin-Based Tuberculosis Treatment in Persons With HIV

HIV Infection | Tuberculosis

Peru, Brazil, South Africa, Haiti, Kenya
National Institute of Allergy and Infectious Diseases...
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Recruiting

Protecting Households On Exposure to Newly Diagnosed Index Multidrug-Resistant Tuberculosis Patients (PHOENIx MDR-TB)

Tuberculosis, MDR

Haiti, Tanzania, Thailand, Botswana, Brazil, India, Kenya, Peru, Philippines, South Africa, Uganda, Zimbabwe, Vietnam
Hospital de Clinicas de Porto Alegre
Federal University of Rio Grande do Sul

Completed

Intervention in the Management of Post-high Tuberculosis Hospital Through Educational Strategy and Oversight Distance

Pulmonary Tuberculosis | Extra Pulmonary Tuberculosis

Brazil
Hospices Civils de Lyon

Completed

Optimization of Tuberculosis Intradermal Skin Test (TB Dermatest)

Healthy Volunteers

France
Weill Medical College of Cornell University

Completed

A 14 Day Early Bactericidal Activity Study of Nitazoxanide for the Treatment of Tuberculosis

Tuberculosis

Haiti
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

REMEMBER: Reducing Early Mortality & Morbidity by Empiric Tuberculosis (TB) Treatment (REMEMBER)

HIV Infection

Peru, Malawi, Uganda, South Africa, India, Haiti, Zambia, Zimbabwe, Brazil, Kenya
National Institute of Allergy and Infectious Diseases...

Completed

Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)

HIV Infections | Tuberculosis

Brazil, United States, Kenya, Peru, South Africa, Thailand, Botswana, Haiti, Malawi, Zimbabwe
Hopital Lariboisière

Completed

Labial Biopsy in Patients With Tuberculosis Disease

Tuberculosis | Sarcoidosis

France
French National Agency for Research on AIDS and...

Completed

Evaluation of 2 Interferon γ Assays in the Diagnosis of Latent Tuberculosis in HIV-infected Patients.ANRS EP 40 QUANTI SPOT

HIV Infections | Tuberculosis

France
Pfizer

Completed

A Randomized Study of Daily and Intermittent Prophylactic Regimens for the Prevention of Disseminated Mycobacterium Avium Complex (MAC) and Fungal Infections in HIV-Infected Patients

HIV Infections | Mycoses | Mycobacterium Avium-Intracellulare Infection

United States
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Immediate Versus Deferred Start of Anti-HIV Therapy in HIV-Infected Adults Being Treated for Tuberculosis (STRIDE)

HIV Infection | Tuberculosis

United States, Peru, Kenya, Malawi, Uganda, Brazil, South Africa, Zimbabwe, India, Thailand, Botswana, Haiti, Zambia
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

High-Dose Isoniazid Among Adult Patients With Different Genetic Variants of INH-Resistant Tuberculosis (TB)

Tuberculosis

Haiti, South Africa
National Institute of Allergy and Infectious Diseases...

Completed

Early Versus Standard Start of Anti-HIV Therapy for Treatment-Naive Adults in Haiti

HIV Infections | Tuberculosis

Haiti
Brigham and Women's Hospital
Weill Medical College of Cornell University; University of California, Davis; Florida International University and other collaborators

Completed

A Trial of Same-Day Testing and Treatment to Improve Outcomes Among Symptomatic Patients Newly Diagnosed With HIV

HIV/AIDS | Tuberculosis

Haiti
Pfizer

Completed

A Randomized, Double-Blind, Comparative Study of Azithromycin Versus Clarithromycin in Combination With Ethambutol for the Treatment of Disseminated Mycobacterium Avium Complex (MAC) Infection in AIDs Patients

HIV Infections | Mycobacterium Avium-intracellulare Infection

United States
National Institute of Allergy and Infectious Diseases...

Recruiting

Linezolid Dosing Strategies in Drug-Resistant TB

Tuberculosis | Tuberculosis, Pulmonary | Tuberculosis, Multidrug-Resistant

Brazil, India, Kenya, Philippines, South Africa, Zimbabwe, Thailand, Haiti, Peru, Botswana
Assistance Publique - Hôpitaux de Paris

Recruiting

MoMa Signature During Granulomatosis (MOSAR)

Tuberculosis | Sarcoidosis

France

Clinical Trials on Mycobacterium Infections, Non-tuberculous in France

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo, DR of

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations